Global Neuromyelitis Optica Drug Market Survey and Trend Research 2018
Summary
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Neuromyelitis Optica Drug Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 NEUROMYELITIS OPTICA DRUG MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Pfizer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 FRESENIUS (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 TEVA (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 SANDOZ (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Gyjtrs (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Gyjtrs (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 NANG KUANG (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Tianjin Kingyork (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Baxter (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 CSL (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Grifols (Company Overview, Sales Data etc.)
4.12 Octapharma (Company Overview, Sales Data etc.)
4.13 CBOP (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Neuromyelitis Optica Drug Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 NEUROMYELITIS OPTICA DRUG MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Pfizer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 FRESENIUS (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 TEVA (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 SANDOZ (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Gyjtrs (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Gyjtrs (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 NANG KUANG (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Tianjin Kingyork (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Baxter (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 CSL (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Grifols (Company Overview, Sales Data etc.)
4.12 Octapharma (Company Overview, Sales Data etc.)
4.13 CBOP (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table GLOBAL NEUROMYELITIS OPTICA DRUG MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Neuromyelitis Optica Drug Market 2012-2017, by Type, in Volume
Table Global Neuromyelitis Optica Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Neuromyelitis Optica Drug Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table Neuromyelitis Optica Drug Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FRESENIUS Overview List
Table Neuromyelitis Optica Drug Business Operation of FRESENIUS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TEVA Overview List
Table Neuromyelitis Optica Drug Business Operation of TEVA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SANDOZ Overview List
Table Neuromyelitis Optica Drug Business Operation of SANDOZ (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gyjtrs Overview List
Table Neuromyelitis Optica Drug Business Operation of Gyjtrs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gyjtrs Overview List
Table Neuromyelitis Optica Drug Business Operation of Gyjtrs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NANG KUANG Overview List
Table Neuromyelitis Optica Drug Business Operation of NANG KUANG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tianjin Kingyork Overview List
Table Neuromyelitis Optica Drug Business Operation of Tianjin Kingyork (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Baxter Overview List
Table Neuromyelitis Optica Drug Business Operation of Baxter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Overview List
Table Neuromyelitis Optica Drug Business Operation of CSL (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Grifols Overview List
Table Neuromyelitis Optica Drug Business Operation of Grifols (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Octapharma Overview List
Table Neuromyelitis Optica Drug Business Operation of Octapharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CBOP Overview List
Table Neuromyelitis Optica Drug Business Operation of CBOP (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Neuromyelitis Optica Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Neuromyelitis Optica Drug Sales Revenue Share, by Companies, in USD Million
Table Global Neuromyelitis Optica Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Neuromyelitis Optica Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Neuromyelitis Optica Drug Demand 2012-2017, by Application, in USD Million
Table Neuromyelitis Optica Drug Demand 2012-2017, by Application, in Volume
Table Neuromyelitis Optica Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Neuromyelitis Optica Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Neuromyelitis Optica Drug Market 2012-2017, by Region, in USD Million
Table Global Neuromyelitis Optica Drug Market 2012-2017, by Region, in Volume
Table Neuromyelitis Optica Drug Market Forecast 2018-2023, by Region, in USD Million
Table Neuromyelitis Optica Drug Market Forecast 2018-2023, by Region, in Volume
Table GLOBAL NEUROMYELITIS OPTICA DRUG MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Neuromyelitis Optica Drug Market 2012-2017, by Type, in Volume
Table Global Neuromyelitis Optica Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Neuromyelitis Optica Drug Market Forecast 2018-2023, by Type, in Volume
Table Pfizer Overview List
Table Neuromyelitis Optica Drug Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FRESENIUS Overview List
Table Neuromyelitis Optica Drug Business Operation of FRESENIUS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TEVA Overview List
Table Neuromyelitis Optica Drug Business Operation of TEVA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SANDOZ Overview List
Table Neuromyelitis Optica Drug Business Operation of SANDOZ (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gyjtrs Overview List
Table Neuromyelitis Optica Drug Business Operation of Gyjtrs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gyjtrs Overview List
Table Neuromyelitis Optica Drug Business Operation of Gyjtrs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NANG KUANG Overview List
Table Neuromyelitis Optica Drug Business Operation of NANG KUANG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tianjin Kingyork Overview List
Table Neuromyelitis Optica Drug Business Operation of Tianjin Kingyork (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Baxter Overview List
Table Neuromyelitis Optica Drug Business Operation of Baxter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Overview List
Table Neuromyelitis Optica Drug Business Operation of CSL (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Grifols Overview List
Table Neuromyelitis Optica Drug Business Operation of Grifols (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Octapharma Overview List
Table Neuromyelitis Optica Drug Business Operation of Octapharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CBOP Overview List
Table Neuromyelitis Optica Drug Business Operation of CBOP (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Neuromyelitis Optica Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Neuromyelitis Optica Drug Sales Revenue Share, by Companies, in USD Million
Table Global Neuromyelitis Optica Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Neuromyelitis Optica Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Neuromyelitis Optica Drug Demand 2012-2017, by Application, in USD Million
Table Neuromyelitis Optica Drug Demand 2012-2017, by Application, in Volume
Table Neuromyelitis Optica Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Neuromyelitis Optica Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Neuromyelitis Optica Drug Market 2012-2017, by Region, in USD Million
Table Global Neuromyelitis Optica Drug Market 2012-2017, by Region, in Volume
Table Neuromyelitis Optica Drug Market Forecast 2018-2023, by Region, in USD Million
Table Neuromyelitis Optica Drug Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Neuromyelitis Optica Drug Industry Chain Structure
Figure Global Neuromyelitis Optica Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Neuromyelitis Optica Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Neuromyelitis Optica Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Neuromyelitis Optica Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Neuromyelitis Optica Drug Industry Chain Structure
Figure Global Neuromyelitis Optica Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Neuromyelitis Optica Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Neuromyelitis Optica Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Neuromyelitis Optica Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
